Professional
Added to YB: 2025-05-19
Pitch date: 2025-05-15
TOI [bullish]
Starling Oncology, Inc.
+108.95%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Starling Oncology, Inc., an oncology company, provides various oncology services in the United States.
Market Cap
$638.0M
Pitch Price
$3.13
Price Target
7.00 (+5%)
Dividend
N/A
EV/EBITDA
-77.56
P/E
-20.58
EV/Sales
1.19
Sector
Health Care Providers and Services
Category
growth
Show full summary:
BTIG Initiates The Oncology Institute (TOI) at Buy with $7 Price Target
TOI: BTIG Buy w/ $7 PT. Cancer care provider blending fee-for-service, capitated & value-based contracts. Aging population & rising Medicare Advantage costs will drive fee-for-service revenue through 2025. Expect increasing demand for capitated/managed care sub-contracted risk.
Read full article (1 min)